References
- Honjo S, Hirano C, Murase S eta].Obsessive-compulsive symptoms inchildhood and adolescence. Acta Psych. Land. 80,83–91 (1989).
- Karno M, Golding JM, Sorenson SB. The epidemiology of obsessive-compulsive disorder in five US communities. Arch. Gen Psychiati y45, 1094–1099 (1988).
- Swedo SE, Rapoport JL, Leonard HL, Lenane M, Cheslow D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch. Gen Psych. 46, 335–342 (1989).
- Valleni-Basile LA, Garrison CZ, Jackson KL etal Frequency of obsessive-compulsive disorder in a community sample of young adolescents. jAm Acad. Child Adolesc. fiychiatry33,782–791 (1994).
- Thomsen PH. Obsessive-compulsive disorder in children and adolescents. A phenomenologic analysis of 61 Danish patients. Psychopathology24, 12–18 (1991).
- Flament M, Whitaker A, Rapoport JL eta]. Obsessive compulsive disorder in adolescence: an epidemiological study. Am. Acad. Child. Adolesc Psychiatry 27, 764–771 (1988).
- Leonard HL, Swedo SE, Lenane M etal A two to seven year follow-up study of 54 obsessive compulsive children and adolescents. Arch. Gen. Psych. 50,429-439 (1993).
- Thomsen PH. Children and adolescentswith obsessive-compulsive disorder. A 6–22 year follow-up study. Clinical descriptions of the course and continuity of obsessive compulsive symptomatology. Eur. Child. Adolesc. PTchiatry 3,82–96 (1994).
- Barr L, Goodman WK, Price LH,McDougle CJ, Charney DS. The serotonin hypothesis of obsessive-compulsive disorder: Implications of pharmacologic challenge studies. j Clin. Psychiatry 53,17–28 (1992).
- Insel TR. Neurobiology of obsessive- compulsive disorder: A review. Int. Clin. fiychophatmacol 7, 31–33 (1992).
- Thorén P, Asberg M, Cronholm B.Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical study. Arch. Gen. Psych. 37,1281–1285 (1980).
- Flament M, Rapoport JL, Berg CJ et alClomipramine treatment of childhood obsessive compulsive disorder: a double-blind controlled study. Arch. Gen. Psych. 42, 977–983 (1985).
- DeVeaugh-Geiss J, Moroz G, Biederman J eta]. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. Am. Acad. Child. Adolesc Psychiatry31, 45–49 (1992).
- Alderman J, Wolkow R, Chung M,Johnston HE Sertraline treatment of children and adolescents with obsessive-compulsive disorder: pharmacokinetics, tolerability and efficacy. jAm. Acad. Child Adolesc. PTchiatry37, 386–394 (1998).
- Riddle MA, Scahill M, King RA eta].Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. j Am Acad. Child Adolesc Psychiatry31, 1062–1069 (1992).
- Riddle M, Claghorn J, Gaffney G etal A controlled trial of fluvoxamine for obsessive-compulsive disorder in children and adolescents. PTchophatmacol Bull. 32, 399–399 (1996).
- March JS, Biederman J, Wolkow R et alSertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JA/V/4 280,1752–1756 (1998).
- Thomsen PH, Ebbesen C, Persson C.Long-term experience with citalopram in the treatment of adolescent OCD. j Am. Acad. Child Adolesc Psychiatry (2001).
- •A 2-year follow-up of 30 adolescents with severe OCD treated with citaloprarn.
- Thomsen PH. Obsessive-compulsive disorder in children and adolescents. Self-reported obsessive-compulsive behaviour in pupils in Denmark. Acta Psych. Scand 88, 212–217 (1993).
- McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S, Leckman JF, Price LH. Risperidone addition in fluvo,au-nine-refractory obsessive-compulsive disorder: three cases. Cl/n. Bychiatry56, 526–528 (1995).
- Thomsen PH, Mikkelsen HU. The additionof buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. Eur Child Adolesc. Psychiatry8, 143–148 (1999).
- Leonard HL, Swedo SE, Rapoport JL et alTreatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. Arch. Gen Psych. 46,1088–1092 (1989).
- March JS, Leonard HL. Obsessive- compulsive disorder in children and adolescents: a review of the past 10 years. Am. Acad. Child Adolesc. Psychiatry 35, 1265–1273 (1996).
- Cook EH, Wagner KD, March JS eta].Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. jAm Acad. Child Adolesc. Psychiatry 40, 1175–1181 (2001).
- •A 1-year open-label study of sertraline in the treatment of pediatric OCD.
- Riddle MA, Reeve EA, Yaryura-Tobias JAetal Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. j Am. Acad. Child Adolesc. PTchiatry 40, 222–229 (2001).